Credit Suisse Ag Catalent, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Catalent, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 210,037 shares of CTLT stock, worth $13.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

210,037

Previous 328,305 36.02%

Holding current value

$13.3 Million

Previous $14.8 Million 19.62%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$42.56 - $59.82 $5.03 Million - $7.07 Million	-118,268 Reduced 36.02%	210,037 $11.9 Million
Q4 2023 Feb 08, 2024	BUY	$32.18 - $46.57 $79,066 - $114,422	2,457 Added 0.75%	328,305 $14.8 Million
Q3 2023 Nov 13, 2023	SELL	$44.2 - $50.2 $504,189 - $572,631	-11,407 Reduced 3.38%	325,848 $14.8 Million
Q2 2023 Aug 11, 2023	BUY	$31.86 - $67.26 $1.03 Million - $2.18 Million	32,346 Added 10.61%	337,255 $14.6 Million
Q1 2023 May 10, 2023	BUY	$45.44 - $74.26 $1.14 Million - $1.86 Million	25,046 Added 8.95%	304,909 $20 Million
Q4 2022 Feb 13, 2023	BUY	$41.39 - $81.0 $956,647 - $1.87 Million	23,113 Added 9.0%	279,863 $12.6 Million
Q3 2022 Nov 10, 2022	SELL	$72.36 - $113.1 $261,002 - $407,951	-3,607 Reduced 1.39%	256,750 $18.6 Million
Q2 2022 Aug 12, 2022	BUY	$87.2 - $114.05 $1.22 Million - $1.6 Million	14,030 Added 5.7%	260,357 $27.9 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $1.15 Million - $1.52 Million	12,242 Added 5.23%	246,327 $27.3 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $830,054 - $965,423	-6,942 Reduced 2.88%	234,085 $30 Million
Q3 2021 Nov 12, 2021	SELL	$109.17 - $142.35 $380,784 - $496,516	-3,488 Reduced 1.43%	241,027 $32.1 Million
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $4.48 Million - $5.17 Million	44,671 Added 22.35%	244,515 $26.7 Million
Q1 2021 May 14, 2021	SELL	$101.51 - $125.27 $912,676 - $1.13 Million	-8,991 Reduced 4.31%	199,844 $21 Million
Q4 2020 Feb 12, 2021	SELL	$85.88 - $105.36 $6.32 Million - $7.75 Million	-73,581 Reduced 26.05%	208,835 $21.7 Million
Q3 2020 Nov 13, 2020	BUY	$72.74 - $92.5 $6.78 Million - $8.62 Million	93,161 Added 49.23%	282,416 $24.2 Million
Q2 2020 Aug 12, 2020	BUY	$48.02 - $79.04 $3.21 Million - $5.29 Million	66,928 Added 54.71%	189,255 $13.9 Million
Q1 2020 May 13, 2020	BUY	$36.95 - $62.95 $249,153 - $424,471	6,743 Added 5.83%	122,327 $6.36 Million
Q4 2019 Feb 12, 2020	BUY	$47.06 - $56.64 $15,435 - $18,577	328 Added 0.28%	115,584 $6.51 Million
Q3 2019 Nov 12, 2019	BUY	$47.45 - $58.05 $830,280 - $1.02 Million	17,498 Added 17.9%	115,256 $5.49 Million
Q2 2019 Aug 14, 2019	SELL	$39.26 - $54.21 $88,452 - $122,135	-2,253 Reduced 2.25%	97,758 $5.3 Million
Q1 2019 May 14, 2019	SELL	$29.84 - $43.92 $561,678 - $826,706	-18,823 Reduced 15.84%	100,011 $4.06 Million
Q4 2018 Feb 13, 2019	SELL	$29.95 - $46.34 $676,540 - $1.05 Million	-22,589 Reduced 15.97%	118,834 $3.71 Million
Q3 2018 Nov 13, 2018	SELL	$40.12 - $45.55 $1.03 Million - $1.17 Million	-25,636 Reduced 15.35%	141,423 $6.44 Million
Q2 2018 Aug 14, 2018	SELL	$38.72 - $42.52 $6.64 Million - $7.29 Million	-171,499 Reduced 50.66%	167,059 $7 Million
Q1 2018 May 15, 2018	BUY	$39.4 - $47.39 $3.01 Million - $3.63 Million	76,519 Added 29.2%	338,558 $13.9 Million
Q4 2017 Feb 14, 2018	BUY	$37.27 - $43.02 $1.34 Million - $1.55 Million	36,071 Added 15.96%	262,039 $10.8 Million
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $4.27 Million - $5.27 Million	126,481 Added 127.13%	225,968 $9.02 Million
Q2 2017 Aug 14, 2017	BUY	N/A	99,487	99,487 $3.49 Million

Others Institutions Holding CTLT

# of Institutions

515

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account